ON COMPLEX TREATMENT OF HYPERACTIVITY OF THE URINARY BLADDER IN WOMEN
https://doi.org/10.24884/1561-6274-2005-9-4-89-92
Abstract
THE AIM of the investigation was to study the efficiency of complex treatment of women with hyperactivity of the urinary bladder. PATIENTS AND METHODS. Treatment of 67 women with hyperactivity of the urinary bladder included administration of Detruzitol (Tolterodin) 2 mg daily during 3 months. Simultaneously with the medicamentous treatment the urinary bladder was trained. Efficiency of the treatment was assessed according to journals of urination, results of cystometry before and after treatment as by the subjective estimation of the patients. RESULTS. After treatment 15 (22.4%) women noted complete disappearance of symptoms of disturbances of urination, 42 (62.7%) showed an improvement, and 10 (14.9%) women had no changes in the symptoms of the disease. Positive dynamics in the objective parameters was found: less frequency of urination, increased volume of filling the bladder by the moment of the appearance of the first and maximal unstable reduction of Detruzitol, increase of the maximal cytometric capacity of the urinary bladder. The most frequent side effect was xerostomia (20.9% of the patients). CONCLUSION. Complex therapy of hyperactivity of the urinary bladder was shown to be highly effective and resulted in complete or partial healing in 85.1% of the patients.
About the Author
I. V. Kuzmin
Санкт-Петербургский государственный медицинский университет им.акад.И.П.Павлова
Russian Federation
Russian Federation
References
1. Abrams PH, Cardozo L, Fall M et al. The standardization of terminology of lower urinary tract function: report from the Standardization SubCommittee of the International Continence Society. Neurourol Urodyn 2002; 21:167178
2. Mundy AR, Stephenson TP. The urge syndrome. In: Mundy AR,Stephenson TP, Wein AJ, eds. Urodynamics: Principles, Practice and Application. Churchill Livingstone, Edinburgh: 1984; 212228
3. Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A populationbased prevalence study. BJU Int 2001; 87: 760766
4. Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20 (6): 327336
5. Abrams PH. Detrusor instability and bladder outlet obstruction. Neurourol Urodyn 1985; 4: P.317
6. Hinman FJr. Critique of Urodynamics. In: Krane RJ, Siroky MB eds. Clinical Neuro-Urology. Little, Brown, Boston:1991; 161
7. Jequier AM. Urinary symptoms in total hysterectomy. Br J Urol 1976; 48: 437
8. Morris AR, Mullan G, Roscioli T et al. A genetic linkage study of detrusor overactivity. Neurourol Urodyn 2004; 23 (5/6): 404
9. АльШукри СХ, Кузьмин ИВ. Гиперактивность детрузора и ургентное недержание мочи. Пособие для врачей. СанктПетербург, 2001; 48
10. Chapple CR. Muscarinic receptor antagonists in the treatment of overactive bladder. Urology 2000; 55 [Suppl.5A]: 3346
11. Wyman JF, Fantl JA. Bladder training in ambulatory care management of urinary incontinence. Urol Nurs 1991; 3: 1117
Review
For citations:
Kuzmin I.V. ON COMPLEX TREATMENT OF HYPERACTIVITY OF THE URINARY BLADDER IN WOMEN. Nephrology (Saint-Petersburg). 2005;9(4):89-92. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-4-89-92
Views:
313
Email this article 